To read this content please select one of the options below:

The role of clusters in the global innovation strategy of MNEs: Theoretical foundations and evidence from the Basel pharmaceutical cluster

Philippe Gugler (Center for Competitiveness, University of Fribourg, Fribourg, Switzerland)
Michael Keller (Center for Competitiveness, University of Fribourg, Fribourg, Switzerland)
Xavier Tinguely (Center for Competitiveness, University of Fribourg, Fribourg, Switzerland)

Competitiveness Review

ISSN: 1059-5422

Article publication date: 18 May 2015

947

Abstract

Purpose

This paper aims to focus on the role of clusters as home and host country-specific advantages for multinational enterprises (“MNEs”) in the organization of their internal and external networks to optimize the diffusion and generation of new knowledge. Strategic asset-seeking investment has been a major driver of the internalization of innovation activities performed by MNEs abroad. This paper demonstrates the attractiveness of foreign clusters in the global innovation process of MNEs. The main assumption is that location within innovative clusters may foster the ability of firms to generate new innovations.

Design/methodology/approach

This paper illustrates the theoretical developments through the example of firms located in the Basel pharmaceutical clusters which have invested in other clusters abroad.

Findings

The results are based on an in-depth patent data analysis and confirm the importance of clusters in an innovation-driven industry.

Originality/value

This paper focuses on the role of clusters as home and host country-specific advantages for “MNEs” in the organization of their internal and external networks to optimize the diffusion and generation of new knowledge. Strategic asset-seeking investment has been a major driver of the internalization of innovation activities performed by MNEs abroad. This paper demonstrates the attractiveness of foreign clusters in the global innovation process of MNEs. The main assumption is that location within innovative clusters may foster the ability of firms to generate new innovations. This paper illustrates the theoretical developments through the example of firms located in the Basel pharmaceutical clusters which have invested in other clusters abroad. The results are based on an in-depth patent data analysis and confirm the importance of clusters in an innovation-driven industry.

Keywords

Citation

Gugler, P., Keller, M. and Tinguely, X. (2015), "The role of clusters in the global innovation strategy of MNEs: Theoretical foundations and evidence from the Basel pharmaceutical cluster", Competitiveness Review, Vol. 25 No. 3, pp. 324-340. https://doi.org/10.1108/CR-09-2014-0033

Publisher

:

Emerald Group Publishing Limited

Copyright © 2015, Emerald Group Publishing Limited

Related articles